• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

CollPlant

CollPlant wins Israeli grant for BioInk 3D printed organs

June 26, 2018 By Fink Densford

Regenerative medicine company CollPlant said today it received agrant from the Israel Innovation Authority to help support its plant-based rhCollagen technology for tissue repairs. The grant will specifically support uses of its rhCollagen-based formulations intended for use as BioInk for 3D printing tissues and organs, the company said. The total budget for the program $1.2 million (NIS […]

Filed Under: Business/Financial News, Regenerative Medicine, Research & Development Tagged With: CollPlant

CollPlant raises $5m in private placement

September 11, 2017 By Fink Densford

Regenerative medicine company CollPlant said today it inked a $5 million private placement deal to support its plant-based rhCollagen technology for tissue repairs. As part of the private placement round, Israel-based CollPlant said it will pursue an up-listing of its ADSs on the Nasdaq exchange following the 1st phase of the transaction closing, which is slated […]

Filed Under: Business/Financial News, Regenerative Medicine Tagged With: CollPlant

New CollPlant division focuses on 3D bioprinting

May 11, 2017 By Chris Newmarker

Regenerative medicine company CollPlant said Thursday that it has created a new division to focus on collagen-based bioprinting. CollPlant has been utilizing its proprietary plant-based rhCollagen technology for tissue repair. The new division will further develop collagen-based bioink for use in 3D printers creating organs and tissues. The Ness Ziona, Israel–based company says it has 3D […]

Filed Under: Biotech, News Well, Regenerative Medicine, Research & Development, Wound Care Tagged With: 3D printing, bioinks, bioprinting, CollPlant, MedTech

7 medtech stories we missed this week: April 14, 2017

April 14, 2017 By Danielle Kirsh

From FDA approvals to business expansion plans, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. BioTelemetry launches offer to acquire LifeWatch BioTelemetry and LifeWatch announced in an April 9 press release that the 2 companies have entered a transaction agreement that states BioTelemetry will launch a tender offer […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Regulatory/Compliance, Research & Development Tagged With: Acelity, BioTelemetry, CollPlant, LifeWatch, MedTech, second-sight-medical, Sight Sciences, Toshiba

CollPlant files for $25 million IPO

October 25, 2016 By Fink Densford

Regenerative medicine company CollPlant today released information on its planned initial public offering, looking to bring in $25 million. CollPlant produces wound care and regenerative devices based on plant-derived collagen. Their products include the Vergenix FG flowable gel intended to treat chronic and acute wounds. The wound-filling gel utilizes Israel-based CollPlant’s proprietary tobacco plant-based technology, […]

Filed Under: Business/Financial News, Initial Public Offering (IPO), Regenerative Medicine Tagged With: CollPlant

CollPlant jumps on CE Mark win for wound filler

February 23, 2016 By Fink Densford

CollPlant said today it won CE Mark approval in the European Union for its Vergenix FG flowable gel intended to treat chronic and acute wounds. In response to the news, the company’s share price was up 4.62% on the Tel Aviv Stock Exchange at midday. The wound-filling gel utilizes Israel-based CollPlant’s proprietary tobacco plant-based technology […]

Filed Under: Regenerative Medicine, Regulatory/Compliance, Wound Care Tagged With: CollPlant

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS